Canada Pension Plan Investment Board
BCRX icon

Canada Pension Plan Investment Board’s BioCryst Pharmaceuticals BCRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
115,805
-2,200
-2% -$19.9K ﹤0.01% 987
2026
Q1 		$1.12M Sell
118,005
-209,936
-64% -$1.63M ﹤0.01% 993
2025
Q4 		$2.56M Buy
327,941
+97,600
+42% +$706K ﹤0.01% 899
2025
Q3 		$1.75M Sell
230,341
-280,000
-55% -$2.33M ﹤0.01% 933
2025
Q2 		$4.57M Buy
510,341
+499,700
+4,696% +$4.65M ﹤0.01% 722
2025
Q1 		$79.8K Hold
10,641
– – ﹤0.01% 1161
2024
Q4 		$80K Hold
10,641
– – ﹤0.01% 1276
2024
Q3 		$80.9K Sell
10,641
-103,159
-91% -$784K ﹤0.01% 1194
2024
Q2 		$703K Hold
113,800
– – ﹤0.01% 1038
2024
Q1 		$578K Hold
113,800
– – ﹤0.01% 1094
2023
Q4 		$682K Hold
113,800
– – ﹤0.01% 1002
2023
Q3 		$806K Hold
113,800
– – ﹤0.01% 884
2023
Q2 		$801K Hold
113,800
– – ﹤0.01% 859
2023
Q1 		$949K Sell
113,800
-70,900
-38% -$683K ﹤0.01% 906
2022
Q4 		$2.12M Buy
184,700
+176,600
+2,180% +$2.2M ﹤0.01% 710
2022
Q3 		$102K Buy
+8,100
New +$104K ﹤0.01% 1081
2022
Q1 		– Sell
-215
Closed -$3K – 1326
2021
Q4 		$3K Buy
+215
New +$2.85K ﹤0.01% 1416
2020
Q1 		– Sell
-749,200
Closed -$2.58M – 1301
2019
Q4 		$2.58M Buy
+749,200
New +$1.88M 0.01% 794

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Canada Pension Plan Investment Board's BCRX Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its BioCryst Pharmaceuticals (BCRX) stake by 1.9% in Q2 2026, selling an estimated $19.9K and leaving 115,805 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Canada Pension Plan Investment Board first reported a position in BCRX in Q4 2019 and has held it in 18 quarters since. The position peaked at $4.57M in Q2 2025. 319 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Canada Pension Plan Investment Board held 115,805 shares of BioCryst Pharmaceuticals worth $1.16M as of Q2 2026.
  • Canada Pension Plan Investment Board sold 2,200 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $19.9K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #987 holding.
  • Canada Pension Plan Investment Board first reported a position in BioCryst Pharmaceuticals in Q4 2019 and has held it in 18 quarters since.
  • Canada Pension Plan Investment Board's BioCryst Pharmaceuticals position peaked at $4.57M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.